Wockhardt Is First Indian Pharmaceutical Company To Get FDA QIDP Status
Tuesday, September 2, 2014 - 00:20
in Health & Medicine
Wockhardt Limited announced that two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food&Drug Administration (FDA). QIDP status is granted to drugs which act against pathogens which have a high degree of unmet need in their treatment and are identified by the Centers for Disease Control. QIDP status allows for fast track review of the drug application by U.S. FDA, paving way for an early launch. This is the first instance of an Indian Pharmaceutical company receiving a QIDP status. read more